Chimera Catalyst: The Finder Series: Book 1
Description:
Who Decides What is Human... The Corporations, Clones or Chimera?
When Finder is hired to locate charismatic, green-haired Miraluna Rose, it seems like an easy job. Crack into corporate databases, brew up some biologics to enhance his thinking, and get the job done with the help of the Parrot, a bird/dog chimera with the finest traits of both species.
The search takes Finder and the Parrot to the sun-broiled streets of Laxangeles, the canals of Seattle and the weirdly mutated vegetation of the Area. It turns out that it's not a simple missing-person case after all.
Finder discovers that ReMe, a corporation providing medical cloning services, is illegally breeding human/animal chimeras. ReMe is selling these exotically beautiful female creatures, branded as ArcoTypes, as playthings to the wealthy and ruthless.
Miraluna Rose is its finest creation, but she has other ideas. She's holed up at Refuge, a haven for ArcoTypes, where she's planning a future of freedom for her sisters.
To help the ArcoTypes fight ReMe, Finder and the Parrot will need the help of a couple of sympathetic AIs, the CEO of the world's largest advertising company and a posse of highly modded, celebrity-crazed media kids.
This exciting adventure is a must read for anyone concerned about where our world and humanity is possibly headed...
Best prices to buy, sell, or rent ISBN 9781945502804
Frequently Asked Questions about Chimera Catalyst: The Finder Series: Book 1
The price for the book starts from $16.07 on Amazon and is available from 7 sellers at the moment.
If you’re interested in selling back the Chimera Catalyst: The Finder Series: Book 1 book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Chimera Catalyst: The Finder Series: Book 1 book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.